D:\My Documents\Wordperfect

Total Page:16

File Type:pdf, Size:1020Kb

D:\My Documents\Wordperfect ANNEX F DNA repair and mutagenesis CONTENTS Page INTRODUCTION..................................................... 2 I. DNADAMAGEANDREPAIR...................................... 2 A. THEROLEOFDNAREPAIRGENESINCELLFUNCTION .......... 2 B. TYPESOFDAMAGEANDPATHWAYSOFREPAIR ............... 3 C. SUMMARY................................................. 8 II. REPAIRPROCESSESANDRADIOSENSITIVITY ...................... 9 A. RADIOSENSITIVITYINMAMMALIANCELLSANDHUMANS...... 9 1. The identification of radiosensitive cell lines and disorders ......... 9 2. Mechanisms of enhanced sensitivity in human disorders .......... 11 3. Analysis of genes determining radiosensitivity .................. 12 4. Summary ............................................. 17 B. RELATIONSHIP BETWEEN REPAIR AND OTHERCELLREGULATORYPROCESSES...................... 18 1. Radiosensitivity and defective recombination in the immune system: non-homologousendjoiningofDNAdouble-strandbreaks........ 18 2. Radiosensitivity and the cell cycle ........................... 21 3. Apoptosis:analternativetorepair?.......................... 23 4. Summary.............................................. 25 III. HUMAN RADIATION RESPONSES ................................. 26 A. CONTRIBUTION OF MUTANT GENES TOHUMANRADIOSENSITIVITY ............................. 26 B. INFLUENCEOFREPAIRONRADIATIONRESPONSES............ 29 C. SUMMARY................................................ 32 IV. MECHANISMSOFRADIATIONMUTAGENESIS ..................... 33 A. MUTATIONASAREPAIR-RELATEDRESPONSE................ 33 B. THESPECTRUMOFRADIATION-INDUCEDMUTATIONS......... 35 C. MOLECULAR ANALYSIS OF RADIATION-INDUCED MUTATIONS . 36 D. EFFECTOFRADIATIONQUALITY............................ 39 E. NOVEL MECHANISMS OF GENETIC CHANGE .................. 41 F. MUTATIONFREQUENCIESANDCONSEQUENCES.............. 44 G. SUMMARY................................................ 47 CONCLUSIONS..................................................... 47 References .......................................................... 49 2 ANNEX F: DNA REPAIR AND MUTAGENESIS INTRODUCTION 1. Risk estimates for the induction of human disease are 3. DNA repair is itself controlled by a specific set of obtained primarilyfrom epidemiological studies.Thesestudies genes encoding the enzymes that catalysecellular response can clearly distinguish radiation effects only at relatively high to DNA damage. Loss of repair function, or alteration of doses and dose rates. Togain information at lowdoses and low the control of repair processes, can have very serious dose rates, which are more relevant to typical human radiation consequencesfor cellsand individuals. It isanticipated that exposures, it is necessary to extrapolate the results of these DNA repair plays a critical role in protecting normal studies. To be valid, this extrapolation requires a detailed individuals from radiation effects, including cancer. understanding of the mechanisms by which radiation induces Clinical experience has revealed individuals who are both cancer and genetic disorders. hypersensitivetoradiation and cancer-prone; someofthese individuals have recently been shown to have defects in 2. Several lines of evidence show that sites of radiation- genes involved in the response to DNA damage. induced cell lethality, mutation, and malignant change are situated within the nucleus and that DNA is the primary 4. In recent years there have been significant advances target. When DNA is damaged by radiation, enzymes within in the molecular analysis of repair processes and the the cell nucleus attempt to repair that damage. The efficiency understanding of the mechanisms that induce genetic of the enzymatic repair processes determines the outcome: changes. Additionally, new methods have been developed most commonly, the structure of DNA is repaired correctly to simplify the identification of the genes involved. As the and cellular functions return to normal. If the repair is details of damage-repair processes become clearer, it is unsuccessful, incomplete, or imprecise, the cell may die or seen that these processes have considerable overlap with may suffer alteration and loss of genetic information (seen as other cellular control functions, such as those regulating mutation and chromosomal aberration). These information the cell cycle and immune defences. In this Annex the changes determine heritable genetic defects and are thought Committee continues to review such developments in to be important in the development of radiation-induced molecular radiobiology, as it began to do in Annex E, cancer. The more complete the knowledge of the ways in “Mechanisms of radiation carcinogenesis” of the which human cells respond to damage and of the mechanisms UNSCEAR 1993 Report [U3], in order to improve the underlying the formation of mutations and chromosomal understanding of how radiation effects are manifested in aberrations, the more accurate will be the predictions of the cells and organisms. oncogenic and hereditary effects of ionizing radiation. I. DNA DAMAGE AND REPAIR A. THEROLEOFDNAREPAIRGENES 6. Loss or alteration of information in a specific gene may IN CELL FUNCTION mean that none of that gene product (protein) is formed, or that the protein is less active, or that it is formed in an 5. The information needed to control cellular functions uncontrolled fashion (e.g. at the wrong time or in the wrong such as growth, division, and differentiation is carried by amount). While some minor genetic alterations may not affect the genes. Genes, which are specific sequences of DNA, act protein activity or interactions, others may significantly mainlythrough theproduction ofcomplementarymessages disrupt cellular function. Since certain proteins work in a (mRNA) that are translated into proteins. Proteins can number of different processes or complexes, the loss or have a structural role but commonlywork asenzymes, each impairment of one type of protein can affect several different of which catalyses a particular metabolic reaction. Thus functions of the cell and organism (pleiotropic effect). specific genes contain the code for (encode) specific cellular functions. The production of proteins can be timed 7. A verylarge number of genes, 60,000-70,000 [F14], are so that they work at specific points in the development of required to control the normal functions of mammalian cells a cell or organism, but protein function can also be and organisms. However, the genes form only a small part of controlled by post-translational modifications. These the genome (the complete DNA sequence of an organism), the modifications are carried out by other proteins, so that a remainder of which largely consists of many copies of complex set of interactions is necessary to fine-tune repetetive DNA sequence. The genes are linked in linear cellular functions. Proteins involved in important aspects arrays interspersed by non-coding sequences, to form of cell metabolism (e.g. DNA replication) may also work chromosomes located in the cell nucleus. Most genes are in multi-protein complexes [A1]. There is some evidence present in only two copies, each on a separate homologous also that some of the complexes are assembled into larger chromosome, one inherited from the mother and one from the structures situated in defined regions of the nucleus (e.g. father. To monitor damage and to maintain the genes without the nuclear matrix) [H2]. significant alteration is a major concern for the cell. Repair ANNEX F: DNA REPAIR AND MUTAGENESIS 3 processes are common to all organisms from bacteria to are arranged in two linear arrays (or strands) held together by humans and have evolved to correct errors made in replicating hydrogen bonds centrally and linked externally by covalent the genes and to restore damaged DNA. This fact has in bonds to sugar-phosphate residues (the DNA "backbone"). recent years provided a useful tool for molecular geneticists in The adenine base pairs naturally with thymine (A:T base the analysis of repair processes; well characterized micro- pair), while guanine pairs with cytosine (G:C base pair), so organisms can serve as model systems to understand the that one DNA strand has the complementary sequence of the structureandfunction ofrepair genes. Theinformation gained other. The sequence of the bases defines the genetic code; each in this way can sometimes also be used directly to isolate gene has a unique sequence, although certain common human genes of related function [L1]. While the structure and sequences exist in control and structural DNA elements. function of repair genes appears to be highly conserved from Damage to DNA may affect any one of its components, but it lower to higher organisms, the regulation of their activities is the loss or alteration of base sequence that has genetic may differ in different organisms. consequences. 8. The consequences of loss of repair capacity are seen in 12. Ionizing radiation deposits energy in tracks of a number of human syndromes and mutant cell lines. These ionizations from moving charged particles within cells, and showhypersensitivitytoenvironmental agents, and thehuman radiations of different quality may be arbitrarily divided into syndromes often have multiple symptoms, including cancer- sparsely ionizing, or low linear energy transfer (low-LET), proneness, neurological disorder, and immune dysfunction. and densely ionizing (high-LET). Each track of low-LET Good progress has been made over the last few years in radiations, such as x rays or gamma rays, consists of only
Recommended publications
  • Kinetic Analysis of Human DNA Ligase III by Justin R. Mcnally A
    Kinetic Analysis of Human DNA Ligase III by Justin R. McNally A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Biological Chemistry) in the University of Michigan 2019 Doctoral Committee: Associate Professor Patrick J. O’Brien, Chair Associate Professor Bruce A. Palfey Associate Professor JoAnn M. Sekiguchi Associate Professor Raymond C. Trievel Professor Thomas E. Wilson Justin R. McNally [email protected] ORCID iD: 0000-0003-2694-2410 © Justin R. McNally 2019 Table of Contents List of Tables iii List of Figures iv Abstract vii Chapter 1 Introduction to the human DNA ligases 1 Chapter 2 Kinetic Analyses of Single-Strand Break Repair by Human DNA Ligase III Isoforms Reveal Biochemical Differences from DNA Ligase I 20 Chapter 3 The LIG3 N-terminus, in its entirety, contributes to single-strand DNA break ligation 56 Chapter 4 Comparative end-joining by human DNA ligases I and III 82 Chapter 5 A real-time DNA ligase assay suitable for high throughput screening 113 Chapter 6 Conclusions and Future Directions 137 ii List of Tables Table 2.1: Comparison of kinetic parameters for multiple turnover ligation by human DNA ligases 31 Table 2.2: Comparison of single-turnover parameters of LIG3β and LIG1 34 Table 3.1: Comparison of LIG3β N-terminal mutant kinetic parameters 67 Table 4.1: Rate constants for sequential ligation by LIG3β 95 Table 5.1: Comparison of multiple turnover kinetic parameters determined by real-time fluorescence assay and reported values 129 iii List of Figures Figure
    [Show full text]
  • Tricarboxylic Acid Cycle Metabolites As Mediators of DNA Methylation Reprogramming in Bovine Preimplantation Embryos
    Supplementary Materials Tricarboxylic Acid Cycle Metabolites as Mediators of DNA Methylation Reprogramming in Bovine Preimplantation Embryos Figure S1. (A) Total number of cells in fast (FBL) and slow (SBL) blastocysts; (B) Fluorescence intensity for 5-methylcytosine and 5-hydroxymethylcytosine of fast and slow blastocysts of cells from Trophoectoderm (TE) or inner cell mass (ICM). Fluorescence intensity for 5-methylcytosine of cells from the ICM or TE in blastocysts cultured with (C) dimethyl-succinate or (D) dimethyl-α- ketoglutarate. Statistical significance is identified by different letters. Figure S2. Experimental design. Table S1. Selected genes related to metabolism and epigenetic mechanisms from RNA-Seq analysis of bovine blastocysts (slow vs. fast). Genes in blue represent upregulation in slow blastocysts, genes in red represent upregulation in fast blastocysts. log2FoldCh Gene p-value p-Adj ange PDHB −1.425 0.000 0.000 MDH1 −1.206 0.000 0.000 APEX1 −1.193 0.000 0.000 OGDHL −3.417 0.000 0.002 PGK1 −0.942 0.000 0.002 GLS2 1.493 0.000 0.002 AICDA 1.171 0.001 0.005 ACO2 0.693 0.002 0.011 CS −0.660 0.002 0.011 SLC25A1 1.181 0.007 0.032 IDH3A −0.728 0.008 0.035 GSS 1.039 0.013 0.053 TET3 0.662 0.026 0.093 GLUD1 −0.450 0.032 0.108 SDHD −0.619 0.049 0.143 FH −0.547 0.054 0.149 OGDH 0.316 0.133 0.287 ACO1 −0.364 0.141 0.297 SDHC −0.335 0.149 0.311 LIG3 0.338 0.165 0.334 SUCLG −0.332 0.174 0.349 SDHA 0.297 0.210 0.396 SUCLA2 −0.324 0.248 0.439 DNMT1 0.266 0.279 0.486 IDH3B1 −0.269 0.296 0.503 SDHB −0.213 0.339 0.544 DNMT3B 0.181 0.386 0.598 APOBEC1 0.629 0.386 0.598 TDG 0.427 0.398 0.611 IDH3G 0.237 0.468 0.675 NEIL2 0.509 0.572 0.720 IDH2 0.298 0.571 0.720 DNMT3L 1.306 0.590 0.722 GLS 0.120 0.706 0.821 XRCC1 0.108 0.793 0.887 TET1 −0.028 0.879 0.919 DNMT3A 0.029 0.893 0.920 MBD4 −0.056 0.885 0.920 PDHX 0.033 0.890 0.920 SMUG1 0.053 0.936 0.954 TET2 −0.002 0.991 0.991 Table S2.
    [Show full text]
  • Kinase-Dead ATM Protein Is Highly Oncogenic and Can Be Preferentially Targeted by Topo
    1 Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo- 2 isomerase I inhibitors 3 4 Kenta Yamamoto1,2, Jiguang Wang3, Lisa Sprinzen1,2, Jun Xu5, Christopher J. Haddock6, Chen 5 Li1, Brian J. Lee1, Denis G. Loredan1, Wenxia Jiang1, Alessandro Vindigni6, Dong Wang5, Raul 6 Rabadan3 and Shan Zha1,4 7 8 1 Institute for Cancer Genetics, Department of Pathology and Cell Biology, College of Physicians 9 and Surgeons, Columbia University, New York City, NY 10032 10 2 Pathobiology and Molecular Medicine Graduate Program, Department of Pathology and Cell 11 Biology, Columbia University, New York City, NY 10032 12 3 Department of Biomedical Informatics and Department of Systems Biology, College of 13 Physicians & Surgeons, Columbia University, New York City, NY 10032 14 4 Division of Pediatric Oncology, Hematology and Stem Cell Transplantation, Department of 15 Pediatrics, College of Physicians & Surgeons, Columbia University, New York City, NY 10032 16 5 Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California San Diego, 17 La Jolla, CA 92093 18 6 Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University 19 School of Medicine, St. Louis, MO 63104 20 21 Short Title: Topo1 inhibitors target ATM mutated cancers 22 Key Words: ATM, missense mutations, Topo I inhibitors 23 24 Address Correspondence to: Shan Zha at [email protected] 25 26 1 27 ABSTRACT 28 Missense mutations in ATM kinase, a master regulator of DNA damage responses, are 29 found in many cancers, but their impact on ATM function and implications for cancer therapy are 30 largely unknown.
    [Show full text]
  • Error-Prone DNA Repair As Cancer's Achilles' Heel
    cancers Review Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ Heel Daniele Caracciolo, Caterina Riillo , Maria Teresa Di Martino , Pierosandro Tagliaferri and Pierfrancesco Tassone * Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, 88100 Catanzaro, Italy; [email protected] (D.C.); [email protected] (C.R.); [email protected] (M.T.D.M.); [email protected] (P.T.) * Correspondence: [email protected] Simple Summary: Cancer onset and progression lead to a high rate of DNA damage, due to replicative and metabolic stress. To survive in this dangerous condition, cancer cells switch the DNA repair machinery from faithful systems to error-prone pathways, strongly increasing the mutational rate that, in turn, supports the disease progression and drug resistance. Although DNA repair de-regulation boosts genomic instability, it represents, at the same time, a critical cancer vulnerability that can be exploited for synthetic lethality-based therapeutic intervention. We here discuss the role of the error-prone DNA repair, named Alternative Non-Homologous End Joining (Alt-NHEJ), as inducer of genomic instability and as a potential therapeutic target. We portray different strategies to drug Alt-NHEJ and discuss future challenges for selecting patients who could benefit from Alt-NHEJ inhibition, with the aim of precision oncology. Abstract: Error-prone DNA repair pathways promote genomic instability which leads to the onset of cancer hallmarks by progressive genetic aberrations in tumor cells. The molecular mechanisms which Citation: Caracciolo, D.; Riillo, C.; Di foster this process remain mostly undefined, and breakthrough advancements are eagerly awaited. Martino, M.T.; Tagliaferri, P.; Tassone, In this context, the alternative non-homologous end joining (Alt-NHEJ) pathway is considered P.
    [Show full text]
  • Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
    cancers Review Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors Gabriel LaPlante 1 and Wei Zhang 1,2,* 1 Department of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G2W1, Canada; [email protected] 2 CIFAR Azrieli Global Scholars Program, Canadian Institute for Advanced Research, MaRS Centre West Tower, 661 University Avenue, Toronto, ON M5G1M1, Canada * Correspondence: [email protected] Simple Summary: The ubiquitin-proteasome system regulates multiple facets of protein homeostasis to modulate signal transduction in numerous biological processes. Not surprisingly, dysregulation of this delicately balanced system is frequently observed in cancer progression. In the past two decades, researchers in both academia and industry have made significant progress in developing small-molecule inhibitors targeting various components in the ubiquitin-proteasome system for cancer therapy. Here, we aim to provide a comprehensive summary of these efforts. Additionally, we overview the advancements of targeted protein degradation, a recently emerging drug discovery concept in cancer therapy. Abstract: The ubiquitin-proteasome system (UPS) is a critical regulator of cellular protein levels and activity. It is, therefore, not surprising that its dysregulation is implicated in numerous human diseases, including many types of cancer. Moreover, since cancer cells exhibit increased rates of protein turnover, their heightened dependence on the UPS makes it an attractive target for inhibition Citation: LaPlante, G.; Zhang, W. via targeted therapeutics. Indeed, the clinical application of proteasome inhibitors in treatment Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by of multiple myeloma has been very successful, stimulating the development of small-molecule Small-Molecule Inhibitors.
    [Show full text]
  • DNA Strand Break Repair and Neurodegeneration
    DNA strand break repair and neurodegeneration. Article (Accepted Version) Rulten, Stuart L and Caldecott, Keith W (2013) DNA strand break repair and neurodegeneration. DNA repair, 12 (8). pp. 558-567. ISSN 1568-7856 This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/47369/ This document is made available in accordance with publisher policies and may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher’s version. Please see the URL above for details on accessing the published version. Copyright and reuse: Sussex Research Online is a digital repository of the research output of the University. Copyright and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable, the material made available in SRO has been checked for eligibility before being made available. Copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational, or not-for-profit purposes without prior permission or charge, provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. http://sro.sussex.ac.uk DNA Strand Break Repair and Neurodegeneration Stuart L. Rulten and Keith W. Caldecott Genome Damage and Stability Centre, Science Park Road, Falmer, Brighton, BN1 9RQ, UK Correspondence: Stuart L.
    [Show full text]
  • Rational Design of Human DNA Ligase Inhibitors That Target Cellular DNA Replication and Repair
    Research Article Rational Design of Human DNA Ligase Inhibitors that Target Cellular DNA Replication and Repair Xi Chen,1 Shijun Zhong,3 Xiao Zhu,3 Barbara Dziegielewska,1 Tom Ellenberger,4 Gerald M. Wilson,2 Alexander D. MacKerell, Jr.,3 and Alan E. Tomkinson1 1Radiation Oncology Research Laboratory and Marlene and Stewart Greenebaum Cancer Center, 2Department of Biochemistry and Molecular Biology, School of Medicine, 3Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland; and 4Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri Abstract exert their cytotoxic effects by damaging DNA. Unfortunately, these Based on the crystal structure of human DNA ligase I agents also kill normal cells, thereby limiting their utility. There is complexed with nicked DNA, computer-aided drug design growing interest in the identification of DNA repair inhibitors that was used to identify compounds in a database of 1.5 million will enhance the cytotoxicity of DNA-damaging agents because commercially available low molecular weight chemicals that combinations of DNA-damaging agents and DNA repair inhibitors were predicted to bind to a DNA-binding pocket within the have the potential to concomitantly increase the killing of cancer DNA-binding domain of DNA ligase I, thereby inhibiting DNA cells and reduce damage to normal tissues and cells if either the joining. Ten of 192 candidates specifically inhibited purified damaging agent or the inhibitor could be selectively delivered to human DNA ligase I. Notably, a subset of these compounds the cancer cells (1). Because DNA ligation is required during replication and is the was also active against the other human DNA ligases.
    [Show full text]
  • Mechanism of Hepatitis B Virus Cccdna Formation
    viruses Review Mechanism of Hepatitis B Virus cccDNA Formation Lei Wei and Alexander Ploss * 110 Lewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Washington Road, Princeton, NJ 08544, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-609-258-7128 Abstract: Hepatitis B virus (HBV) remains a major medical problem affecting at least 257 million chronically infected patients who are at risk of developing serious, frequently fatal liver diseases. HBV is a small, partially double-stranded DNA virus that goes through an intricate replication cycle in its native cellular environment: human hepatocytes. A critical step in the viral life-cycle is the conversion of relaxed circular DNA (rcDNA) into covalently closed circular DNA (cccDNA), the latter being the major template for HBV gene transcription. For this conversion, HBV relies on multiple host factors, as enzymes capable of catalyzing the relevant reactions are not encoded in the viral genome. Combinations of genetic and biochemical approaches have produced findings that provide a more holistic picture of the complex mechanism of HBV cccDNA formation. Here, we review some of these studies that have helped to provide a comprehensive picture of rcDNA to cccDNA conversion. Mechanistic insights into this critical step for HBV persistence hold the key for devising new therapies that will lead not only to viral suppression but to a cure. Keywords: hepatitis B virus; HBV; viral replication; cccDNA biogenesis; rcDNA; DNA repair Citation: Wei, L.; Ploss, A. 1. Overview of HBV Life Cycle and cccDNA Biogenesis Mechanism of Hepatitis B Virus cccDNA Formation. Viruses 2021, 13, The hepatotropic HBV belongs to the Hepadnaviridae family and is a blood-borne 1463.
    [Show full text]
  • Polymerase Is a Robust Terminal Transferase That Oscillates Between
    RESEARCH ARTICLE Polymerase is a robust terminal transferase that oscillates between three different mechanisms during end-joining Tatiana Kent1,2, Pedro A Mateos-Gomez3,4, Agnel Sfeir3,4, Richard T Pomerantz1,2* 1Fels Institute for Cancer Research, Temple University Lewis Katz School of Medicine, Philadelphia, United States; 2Department of Medical Genetics and Molecular Biochemistry, Temple University Lewis Katz School of Medicine, Philadelphia, United States; 3Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, United States; 4Department of Cell Biology, New York University School of Medicine, New York, United States Abstract DNA polymerase q (Polq) promotes insertion mutations during alternative end-joining (alt-EJ) by an unknown mechanism. Here, we discover that mammalian Polq transfers nucleotides to the 3’ terminus of DNA during alt-EJ in vitro and in vivo by oscillating between three different modes of terminal transferase activity: non-templated extension, templated extension in cis, and templated extension in trans. This switching mechanism requires manganese as a co-factor for Polq template-independent activity and allows for random combinations of templated and non- templated nucleotide insertions. We further find that Polq terminal transferase activity is most efficient on DNA containing 3’ overhangs, is facilitated by an insertion loop and conserved residues that hold the 3’ primer terminus, and is surprisingly more proficient than terminal deoxynucleotidyl transferase. In summary, this report identifies an unprecedented switching mechanism used by Polq to generate genetic diversity during alt-EJ and characterizes Polq as among the most proficient terminal transferases known. DOI: 10.7554/eLife.13740.001 *For correspondence: richard.
    [Show full text]
  • Human RAP 1 Specifically Protects Telomeres of Senescent Cells from DNA Damage Liudmyla Lototska, Jia-Xing Yue, M.J
    Human RAP 1 specifically protects telomeres of senescent cells from DNA damage Liudmyla Lototska, Jia-xing Yue, M.J. Giraud-Panis, Zhou Songyang, Nicola Royle, Gianni Liti, Jing Ye, Eric Gilson, Aaron Mendez-bermudez To cite this version: Liudmyla Lototska, Jia-xing Yue, M.J. Giraud-Panis, Zhou Songyang, Nicola Royle, et al.. Human RAP 1 specifically protects telomeres of senescent cells from DNA damage. EMBO Reports, EMBO Press, 2020, 21 (4), 10.15252/embr.201949076. hal-03013736 HAL Id: hal-03013736 https://hal.archives-ouvertes.fr/hal-03013736 Submitted on 23 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Report Human RAP1 specifically protects telomeres of senescent cells from DNA damage Liudmyla Lototska1,2,†, Jia-Xing Yue2,‡, Jing Li2,‡, Marie-Josèphe Giraud-Panis2, Zhou Songyang3,4,5, Nicola J Royle6 , Gianni Liti2, Jing Ye1,* , Eric Gilson1,2,7,** & Aaron Mendez-Bermudez1,2,#,*** Abstract overhang. Over the course of evolution, mammalian telomeres invented the shelterin complex, a very elegant way to protect chro- Repressor/activator protein 1 (RAP1) is a highly evolutionarily mosome extremities from various DNA damaging insults, including conserved protein found at telomeres.
    [Show full text]
  • Ligase 1 Is a Predictor of Platinum Resistance and Its Blockade Is Synthetically Lethal In
    Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers Reem Ali1*, Muslim Alabdullah1,2*, Mashael Algethami1**, Adel Alblihy1,3**, Islam Miligy2, Ahmed Shoqafi1, Katia A. Mesquita1, Tarek Abdel-Fatah4, Stephen YT Chan4, Pei Wen Chiang5, Nigel P Mongan6,7, Emad A Rakha2, Alan E Tomkinson8, Srinivasan Madhusudan1,3*** 1 Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK. 2 Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK. 3 Medical Center, King Fahad Security College (KFSC), Riyadh 11461, Saudi Arabia. 4 Department of Oncology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK. 5 Department of Obstetrics & Gynaecology, Queens Medical Centre, Nottingham University Hospitals, Nottingham NG7 2UH, UK. 6 Faculty of Medicine and Health Sciences, Centre for Cancer Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Leicestershire LE12 5RD, UK 7 Department of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA 8 Department of Internal Medicine, Division of Molecular Medicine, Health Sciences Center, The University of New Mexico, Albuquerque, NM 87102, USA. * = Joint first authors, ** = Joint second authors Running title: LIG1 targeting in ovarian cancers Declarations of interest: none Word count: 3459 Figure: 5 Table:1 *** Corresponding author: Professor Srinivasan
    [Show full text]
  • Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III
    Genes 2015, 6, 385-398; doi:10.3390/genes6020385 OPEN ACCESS genes ISSN 2073-4425 www.mdpi.com/journal/genes Review Alternative Okazaki Fragment Ligation Pathway by DNA Ligase III Hiroshi Arakawa 1,* and George Iliakis 2 1 IFOM-FIRC Institute of Molecular Oncology Foundation, IFOM-IEO Campus, Via Adamello 16, Milano 20139, Italy 2 Institute of Medical Radiation Biology, University of Duisburg-Essen Medical School, Essen 45122, Germany; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +39-2-574303306; Fax: +39-2-574303231. Academic Editor: Peter Frank Received: 31 March 2015 / Accepted: 18 June 2015 / Published: 23 June 2015 Abstract: Higher eukaryotes have three types of DNA ligases: DNA ligase 1 (Lig1), DNA ligase 3 (Lig3) and DNA ligase 4 (Lig4). While Lig1 and Lig4 are present in all eukaryotes from yeast to human, Lig3 appears sporadically in evolution and is uniformly present only in vertebrates. In the classical, textbook view, Lig1 catalyzes Okazaki-fragment ligation at the DNA replication fork and the ligation steps of long-patch base-excision repair (BER), homologous recombination repair (HRR) and nucleotide excision repair (NER). Lig4 is responsible for DNA ligation at DNA double strand breaks (DSBs) by the classical, DNA-PKcs-dependent pathway of non-homologous end joining (C-NHEJ). Lig3 is implicated in a short-patch base excision repair (BER) pathway, in single strand break repair in the nucleus, and in all ligation requirements of the DNA metabolism in mitochondria. In this scenario, Lig1 and Lig4 feature as the major DNA ligases serving the most essential ligation needs of the cell, while Lig3 serves in the cell nucleus only minor repair roles.
    [Show full text]